Canada markets close in 3 hours 49 minutes

Fractyl Health, Inc. (GUTS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.59-0.11 (-1.57%)
As of 12:06PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close6.69
Open6.66
Bid6.57 x 100
Ask6.66 x 200
Day's Range6.41 - 6.80
52 Week Range5.75 - 14.50
Volume117,058
Avg. Volume309,243
Market Cap315.401M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.00
  • GlobeNewswire

    Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates

    Initiation of Remain-1 pivotal study for weight maintenance in patients with obesity after discontinuation of GLP-1 based drugs expected in the second half of 2024 Topline data from Revitalize-1 pivotal study in patients with inadequately controlled T2D anticipated in the fourth quarter 2024 Update from real-world Germany registry study of Revita in patients with T2D at DDG Annual Meeting Appointed Adrian Kimber as Chief Commercial Officer to lead Revita launch readiness activities Conference ca

  • GlobeNewswire

    Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)

    First 14 participants with at least six months of follow up continue to demonstrate sustained improvements in blood glucose and weight with reduction in T2D medication utilization after a single Revita treatment No device- or procedure-related serious adverse events have been observed to date in any registry participant BURLINGTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches for

  • GlobeNewswire

    Fractyl Health to Present at BofA Securities 2024 Health Care Conference

    BURLINGTON, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (T2D), today announced that Dr. Harith Rajagopalan, CEO of Fractyl Health, will participate in a fireside chat at the upcoming BofA Securities 2024 Health Care Conference on Wednesday, May 15, 2024, at 4:20 p.m. PDT (7:20 p.m. EDT). To register in advance for the fireside cha